Marshall Wace North America’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-12,761
| Closed | -$584K | – | 1373 |
|
|
2020
Q3 | $584K | Buy |
12,761
+3,255
| +34% | +$149K | ﹤0.01% | 933 |
|
|
2020
Q2 | $478K | Sell |
9,506
-7,957
| -46% | -$400K | ﹤0.01% | 931 |
|
|
2020
Q1 | $897K | Buy |
17,463
+462
| +3% | +$23.7K | 0.01% | 631 |
|
|
2019
Q4 | $1.05M | Sell |
17,001
-39,451
| -70% | -$2.43M | 0.01% | 709 |
|
|
2019
Q3 | $3.39M | Buy |
56,452
+1,025
| +2% | +$61.6K | 0.02% | 437 |
|
|
2019
Q2 | $4.68M | Sell |
55,427
-170,267
| -75% | -$14.4M | 0.03% | 379 |
|
|
2019
Q1 | $21.6M | Buy |
225,694
+207,326
| +1,129% | +$19.8M | 0.15% | 137 |
|
|
2018
Q4 | $1.3M | Buy |
+18,368
| New | +$1.3M | 0.01% | 545 |
|
|
2013
Q4 | $1.37M | Buy |
+50,097
| New | +$1.37M | 0.03% | 348 |
|